Chemistry Reference
In-Depth Information
Levoloxacin
Antimicrobial.drug.
(luoroquinolone)
C/Nj.(+dsDNA)
CV,.FIA-AD
5.×.10
−7
-5.×.10
−6
.M;.anodic-activated.CPE;.
studies.on.interaction.with.DNA
Human.urine
[2582]
Lidocaine
Local.anesthetic.and.topical.
pain.reliever.(Et-amino-
benzoate)
C/PO.(+
Chloranil
)
CV,.LSV
Undirect.method.(via.the.decrease.in.signal.
of.modif.),.lin:.sub-μM.level;.simult..detn..
with.
Benzocaine
Model.solns.
[1507]
Lomeloxacin
Antibacterial.agent.
(luoroquinoline.der.)
(a).C/PO.(unm.)
(b)..C/PO.(+ β-.cyclodextrin)
CV,.DPV
simult..detn..with.
Gaf
.and.
Spf
,.(b).with.
Gaf, Nof
,.and.
Ol
.;.(a).LOD:.1.×.10
−7
.M
(b).LOD:.2.×.10
−8
.M,.s.e.:.BRB.(pH.4.0)
Dosage.forms.,.
human.urine.
(dil. and.spiked)
(a).[678]
(b).[1418]
Loprazolam
Hypnoticum.(benzodiazepin-
one)
C/Nj.(unm.)
CV,.DPV
pH.3-10,.LOD:.2.×.10
−7
,.LOQ:.2.×.10
−6
.M;.
studies.on.irrev..oxidn..+.adsorp.
pharm..forms..
(
Somnovit
®
)
[2583]
Magnolol
Antibacterial.agent.(nat..
biphenol.ctnd..in.
Magnolia
.
lower)
C/PO.(+mpSiO
2
.and surf.)
CV,.2nd
.
DeLV
Enhanced.oxidn..peak.(
E
.=.+0.4.vs..ref.).by.
cationic.surfactant;.pH.6.5,.LOD:.10.g.
L
−1
;.simult..detn..with.
Honokiol
pharm..preps,.
(Chinese.med.)
[1671]
Marcellomycin
Antineoplastic.anti-bioticum.
(
Actino- sprangium
.sp.)
C/Nj.(lipids)
CV,.DPV
Studies.on.accum..process,.pH-effect,.CPE.
compared.with.GCE.and.PtE;.MEx,.lin..
range:.1.×.10
−8
-2.×.10
−6
.M
Model.solns..
(spiked.urine)
[1667,2584]
Mefenamic acid
Antiinlammatory.a..
(2,3-dimethyl-phenyl.
aminobenzoic.acid)
C/PO.(+La
III
-NWs)
CV,.2nd
.
DeLSV
NWs:.nanowires;.study.of.oxidn..(via.
1e
−
.and.H
+
).at.effectively.porous.surf..
given.by.NWs;.lin.:.2.×.10
−11
-4.×.10
−9
.M
Model.solns.
[2585]
Meloxicam
Antiinlammatory.
a
..(subst..
benzothiazine.carboxamide.
dioxide)
C/Nj.(unm.)
CV,.LSV
Studies.on.oxidn..mechanism.and.pH;.
BR-B.(pH.3.0),.lin:.5.×.10
−7
-5.×.10
−5
.M
Dosage.forms.
[2586]
Metaproterenol
.
(sulfate)
Sympathomimetic.
a
..(subst..
benzendiol)
(a).C/Nj.(unm.;.
Metrohm
)
(b).C/Nj.(+Naion)
(a).COU
(b).CV,.DPV
(a).Pool-conigured.CPE.(
d
.=.2.cm).used.
for.coulometric.evaln..of.a.number.of.e
−
(b).LOD:.2.×.10
−8
.M;.simult.detn..of.3.d
Model.solns.
[1719]
Metformin
Anti-diabetic.drug.for.oral.
intake.(biguanide.der.)
(a).CNTPE.(+Cu
II
-MWs)
(b).CNTPE.(+Cu
2+
,.
in situ
)
(c).C/PO.[+Mt
+
B(FPh)
4
]
[CP-ISE]
(a).2nd.DeLV
(b).2nd.DeLV
(c).POT.(dir)
(a).MWs:.molecular.wires:.Cu
4
[bis(Py).
propane]
4
(2-methylacrylic.acid)
8
.H
2
O,.
studies.on.irrev.oxidn..and.mechanism.
LOD:.5.×.10
−7
.M;.(b).AmB.(pH.8.9);.lin:.
0.2-10.μM;.(c).pH.4-8,.LOD:.1.×.10
−5
.M
(a-c).Model.solns.
(a).[373]
(b).[2587]
(c).[2588]
Met(h)adone
Anti-opiate.agent.
(dimethylamino-di-phenyl-
heptanone)
C/PO.(unm.)
CV,.DPV
Studies.on.el..reaction.mechanism.and.r..
kinetics,.evaln..of.
k
S
,.α,.
D
X
,.LOD:.1.×.10
−8
.
M;.anodically.pretreated.CPE
Model.solns.
[2589]
(
continued
)
Search WWH ::
Custom Search